The collaboration aims to create a scalable, customized RPM solution that enables effective treatment outside the hospital, while providing near real-time data to the clinician.
Furthermore, AMC Health’s holistic solution enables a clinical team to focus on the whole patient and their unique, frequently complex health conditions as well as anticipate demand for future care, such as potential readmission.
At-home monitoring of chronic disease patients is said to provide the care team with a complete picture of the patient’s condition.
“Pairing AMC Health’s Remote Patient Monitoring suite with GE Healthcare’s clinical monitoring offering will extend care beyond the clinical setting and enable more patients to continue to receive quality care from the comfort of their homes, delivering healthcare without limits,” Ashutosh Banerjee, general manager of diagnostic cardiology and remote patient monitoring at GE Healthcare, said in a statement.
Eventually, the companies intend to combine hospital and home data in GE’s Edison Health database. GE announced nearly a year ago that it would spin off its healthcare unit, GE Healthcare, in early 2023.
The company recently disclosed new information about its efforts to divide the conglomerate into three distinct entities. It intends to divide GE Healthcare into four segments: imaging, ultrasound, patient care solutions (including monitoring and digital tools), and pharmaceutical diagnostics.
According to Validic’s news release, Validic’s technology can directly integrate into Oracle Cerner’s electronic health records (EHR) system, and the company aims to provide remote monitoring technology that improves patient care without putting additional strain on staff.
Remote patient monitoring (RPM) holds enormous promise for improving chronic disease management and treatment.
Like other forms of virtual healthcare, RPM’s use increased during the COVID-19 pandemic. General RPM use increased from 91 claims per 100,000 enrollees in February 2020 to 594 claims per 100,000 enrollees in September 2021, according to a study of Medicare beneficiaries published in JAMA Internal Medicine.